A second look: Discussing IL-33 agents in development for COPD with a focus on Itepekimab

Executed on:May 30, 2025 12:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: Cherokee Lung & Sleep SpecialistsCommunity Pulmonologist who specializes in COPD, asthma, pulmonary nodules and cancers, obstructive and central sleep apneas, complex sleep-disordered breathing, narcolepsy, restless leg syndrome, circadian rhythm disorders and insomnia.
250 COPD patients annually approximately
Very familiar with investigational agents in development for COPD

Interview Goal

Discuss potential of IL-33 inhibition in COPD

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.